Skip to main content
. 2016 Jun 30;4(8):752–755. doi: 10.1002/ccr3.610

Figure 3.

Figure 3

Echocardiogram 5 months after starting treatment with ambrisentan. The tricuspid regurgitation velocity is within normal limits.